"VSports手机版" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site VSports app下载. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Review
. 2013;10(2):e1001380.
doi: 10.1371/journal.pmed.1001380. Epub 2013 Feb 5.

"V体育官网" Prognosis Research Strategy (PROGRESS) 2: prognostic factor research

Collaborators, Affiliations
Review

Prognosis Research Strategy (PROGRESS) 2: prognostic factor research

Richard D Riley et al. PLoS Med. 2013.

Abstract (VSports)

Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved VSports手机版. .

PubMed Disclaimer

VSports app下载 - Conflict of interest statement

SS is a full time employee of the BMJ Group but is not involved in the decision making on manuscripts. The authors declare no other competing interests V体育安卓版.

V体育安卓版 - Figures

Figure 1
Figure 1. Tumour grade as a prognostic factor in breast cancer.
Kaplan-Meier curves for disease-free survival for three groups of breast cancer patients defined by tumour grade status (1, 2, or 3). Curves are derived from 246 breast cancer patients treated with tamoxifen who had 94 recurrences or deaths over a possible 7 years of follow-up (reproduced with published data relating to Schumacher et al [1]). The distinct curves, significant log rank result, and hazard ratio estimates suggests tumour grade is a prognostic factor, as it identifies three groups of patients with a different average prognosis.
Figure 2
Figure 2. Evaluation of whether homocysteine is a prognostic factor, and whether modifying it improves clinical outcome in patients with coronary disease (drawn from data in [35]).
Path element adapted from Chart 7.1 in the Cooksey report (2006) http://bit.ly/Ro27rL (made available for use and re-use through the Open Government License).
Figure 3
Figure 3. Discovery of prognostic factors: a genome-wide association study of survival among people with breast cancer, and replication in 15 studies (Mid-figure forest plot based on example plots in .
Path element adapted from Chart 7.1 in the Cooksey report (2006) http://bit.ly/Ro27rL (made available for use and re-use through the Open Government License).

References

    1. Schumacher M, Bastert G, Bojar H, Hubner K, Olschewski M, et al. (1994) Randomized 2×2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group. J Clin Oncol 12: 2086–2093. - PubMed
    1. Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, et al. (2013) Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes. BMJ 346: e5595. - VSports在线直播 - PMC - PubMed
    1. Riley RD, Sauerbrei W, Altman DG (2009) Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer 100: 1219–1229. - PMC - PubMed
    1. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, et al. (2010) Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 102: 650–662. - PMC (VSports) - PubMed
    1. Mostertz W, Stevenson M, Acharya C, Chan I, Walters K, et al. (2010) Age- and sex-specific genomic profiles in non-small cell lung cancer. JAMA 303: 535–543. - PubMed

Substances